JelloX Research Collaborations Further Demonstrate Promise of 3D Pathology
Results of a Taiwan-based study are expected to be validated in a new collaboration with a major Japanese
Loading...

Results of a Taiwan-based study are expected to be validated in a new collaboration with a major Japanese
First shared at a recent Japanese Society of Digital Pathology meeting, the company is forging a global
Newly published study in collaboration with Japan's NCCHE reveals how AI-powered HER2 and tumor
YANTAI, China, Dec. 13, 2024 /PRNewswire/ -- On the morning of December 12, 2024 (UTC-6), at the Poster
YANTAI, China, Feb. 2, 2024 /PRNewswire/ -- RemeGen Co. Ltd.("RemeGen" or "the Company")
SUZHOU, China, Feb. 27, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) and CSPC Pharmaceutical
Continue reading uninterrupted with a subscription